Serum 25(OH)D3 was previously shown to be negatively associated with non-alcoholic fatty liver disease [25,26], and molecular studies suggest it has a mechanistic role in regulating sterol regulatory element-binding protein cleavage-activating protein complex formation in the liver [27]. The gene discussed is CNBP; the disease is metabolic dysfunction-associated steatotic liver disease.